Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Design and Synthesis of New Substituted Benzyl-1,2,3-Triazole-Methoxybenzylidene Coupled to Arylacetohydrazides Against Alzheimer's Disease Publisher



A Iraji AIDA ; D Shargheiboroujeni DIBA ; A Aliabadi ARIAN ; M Dara MAHINTAJ ; Mh Hashempur Mohammad HASHEM ; R Hariri ROSHANAK ; Dam Khassaki Dhuha Ali MAHDI ; M Saeedi MINA ; T Akbarzadeh TAHMINEH
Authors

Source: Journal of Molecular Structure Published:2025


Abstract

In this work, new hybrids of substituted benzyl-1,2,3-triazole-methoxybenzylidene-arylacetohydrazides were designed and synthesized to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), as one of the most promising strategies for the treatment of Alzheimer's disease (AD). Among them, compound 10c was found potent against AChE and BChE with IC50 values of 18.42 ± 0.89 and 21.25 ± 0.59 μM, respectively. Additionally, the conduct of kinetic and molecular docking studies revealed essential interactions between compound 10c and key catalytic residues of the enzymes. Furthermore, compound 10c revealed low cytotoxicity to downregulate important genes, including GSK-3β and BACE1, related to AD. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs